145 related articles for article (PubMed ID: 33651215)
1. Author Reflections: Relationship of Systemic Inflammatory Response Indicators at Recurrence to Long-Term Outcomes in Patients with Recurrent Esophageal Squamous Cell Carcinoma: The Utility of Neutrophil-to-Lymphocyte Ratio.
Takeuchi M; Hoshino S; Kawakubo H; Matsuda S; Mayanagi S; Irino T; Fukuda K; Nakamura R; Wada N; Kitagawa Y
Ann Surg Oncol; 2021 Jun; 28(6):3009-3010. PubMed ID: 33651215
[No Abstract] [Full Text] [Related]
2. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
Fu X; Li T; Dai Y; Li J
BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
[TBL] [Abstract][Full Text] [Related]
3. The Preoperative Neutrophil to Lymphocyte Ratio Predicts Survival in Patients with Esophageal Squamous Cell Carcinoma: a Propensity Score Matching Analysis.
Zheng Z; Fang L; Zhu H
J Gastrointest Surg; 2023 Sep; 27(9):1944-1946. PubMed ID: 37165159
[No Abstract] [Full Text] [Related]
4. Usefulness of Neutrophil to Lymphocyte Ratio at Recurrence for Predicting Long-Term Outcomes in Patients with Recurrent Esophageal Squamous Cell Carcinoma.
Hoshino S; Takeuchi M; Kawakubo H; Matsuda S; Mayanagi S; Irino T; Fukuda K; Nakamura R; Wada N; Kitagawa Y
Ann Surg Oncol; 2021 Jun; 28(6):3001-3008. PubMed ID: 33689078
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma.
Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z
J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689
[TBL] [Abstract][Full Text] [Related]
6. ASO Author Reflections: Serum Squamous Cell Carcinoma Antigen in Recurrent Esophageal Squamous Cell Carcinoma.
Kanie Y; Okamura A; Watanabe M
Ann Surg Oncol; 2021 Nov; 28(12):7997-7998. PubMed ID: 33860360
[No Abstract] [Full Text] [Related]
7. The Prognostic Role of the Neutrophil to Lymphocyte Ratio at Recurrence in Esophageal Squamous Cell Carcinoma: Challenges and Future Directions.
Kam AE; Masood A
Ann Surg Oncol; 2021 Jun; 28(6):2939-2940. PubMed ID: 33560489
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: Decrease of Albumin and Derived Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Chemotherapy Reflect the Worse Prognosis in Patients with Esophageal Squamous Cell Carcinoma.
Abe T; Oshikiri T; Goto H; Kato T; Horikawa M; Sawada R; Harada H; Urakawa N; Hasegawa H; Kanaji S; Yamashita K; Matsuda T; Kakeji Y
Ann Surg Oncol; 2022 Oct; 29(11):6867-6868. PubMed ID: 35616746
[No Abstract] [Full Text] [Related]
9. Impact of pathologically assessing extranodal extension in the thoracic field on the prognosis of esophageal squamous cell carcinoma.
Okada N; Daiko H; Kanamori J; Sato A; Horikiri Y; Sato T; Fujiwara H; Tomioka T; Fujita T; Kojima T; Fujii S
Surgery; 2019 Jun; 165(6):1203-1210. PubMed ID: 30850155
[TBL] [Abstract][Full Text] [Related]
10. ASO Author Reflections: How Should We Approach Borderline Resectable Esophageal Squamous Cell Carcinoma?
Suzuki T; Okamura A; Watanabe M; Chin K
Ann Surg Oncol; 2020 May; 27(5):1518-1519. PubMed ID: 32108921
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Prognostic Stratification and the Value of Adjuvant Therapy in Thoracic Esophageal Squamous Cell Carcinoma Patients After Esophagectomy.
Deng W; Chen J; Xiao Z
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):802-803. PubMed ID: 31654164
[No Abstract] [Full Text] [Related]
12. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
Ji WH; Jiang YH; Ji YL; Li B; Mao WM
Dis Esophagus; 2016 Jul; 29(5):403-11. PubMed ID: 25625421
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
14. ASO Author Reflections: Additional Esophagectomy After Noncurative Endoscopic Resection Versus Upfront Esophagectomy in Patients with T1N0 Esophageal Squamous Cell Carcinoma.
Maruyama S; Okamura A; Watanabe M
Ann Surg Oncol; 2021 Sep; 28(9):4867-4868. PubMed ID: 33492541
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: Prognostic Role of a Coagulation Index for Patients with Esophageal Squamous Cell Cancer.
Wang Q; Cao B; Mi K
Ann Surg Oncol; 2021 Dec; 28(13):8462-8463. PubMed ID: 34106387
[No Abstract] [Full Text] [Related]
16. Prognostic Significance of the Prognostic Nutritional Index in Patients with Recurrent Esophageal Squamous Cell Carcinoma.
Nakatani M; Migita K; Matsumoto S; Wakatsuki K; Ito M; Nakade H; Kunishige T; Kitano M; Sho M
Nutr Cancer; 2018 Apr; 70(3):467-473. PubMed ID: 29528703
[TBL] [Abstract][Full Text] [Related]
17. Recurrence index predicts the prognosis of patients with pathological T1 esophageal squamous cell carcinoma.
C L; H Z; P K; K M
Asian J Surg; 2022 Mar; 45(3):928-929. PubMed ID: 35000851
[No Abstract] [Full Text] [Related]
18. A Model Shows Utility in Predicting Postoperative Recurrence and Distant Metastasis in Curatively Resected Esophageal Squamous Cell Cancer.
Wang W; Chen Y; Zhang X; Xi K; Feng X; Zhang L
Cancer Control; 2019; 26(1):1073274819852965. PubMed ID: 31146546
[TBL] [Abstract][Full Text] [Related]
19. [Effect of preoperative Nutritional Risk Screening-2002 combined with hematologic inflammatory markers on prognosis of thoracic esophageal squamous cell carcinoma].
Guo XW; Zhu L; Ye HX; Zhou SB; Liu YC; Zhou JY; Ji SJ
Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):604-609. PubMed ID: 31434452
[No Abstract] [Full Text] [Related]
20. ASO Author Reflections: Response to Neoadjuvant Chemotherapy Strengthens the Prognostic Impact of Pathological Stage for Esophageal Squamous Cell Carcinoma.
Matsuda S; Kawakubo H; Okamura A; Takahashi K; Toihata T; Takemura R; Mayanagi S; Takeuchi H; Watanabe M; Kitagawa Y
Ann Surg Oncol; 2021 Dec; 28(13):8448-8449. PubMed ID: 34143335
[No Abstract] [Full Text] [Related]
[Next] [New Search]
